Understanding Radioactive Iodine-Refractory Differentiated Thyroid Cancer (RAI-R-DTC)

Lori Wirth, MD, provides an overview of radioactive iodine-refractory differentiated thyroid cancer (RAI-R-DTC), the standard-of-care treatment options, and the importance of testing for molecular alterations in patients with RAI-R-DTC.